Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.

Nishihara, Hideaki; Engelhardt, Britta (2022). Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective. Handbook of experimental pharmacology, 273, pp. 295-329. Springer 10.1007/164_2020_407

[img] Text
Nishihara-Engelhardt2020_Chapter_BrainBarriersAndMultipleSclero.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (649kB) | Request a copy

Multiple sclerosis (MS) is considered a prototypic organ specific autoimmune disease targeting the central nervous system (CNS). Blood-brain barrier (BBB) breakdown and enhanced immune cell infiltration into the CNS parenchyma are early hallmarks of CNS lesion formation. Therapeutic targeting of immune cell trafficking across the BBB has proven a successful therapy for the treatment of MS, but comes with side effects and is no longer effective once patients have entered the progressive phase of the disease. Beyond the endothelial BBB, epithelial and glial brain barriers establish compartments in the CNS that differ in their accessibility to the immune system. There is increasing evidence that brain barrier abnormalities persist during the progressive stages of MS. Here, we summarize the role of endothelial, epithelial, and glial brain barriers in maintaining CNS immune privilege and our current knowledge on how impairment of these barriers contributes to MS pathogenesis. We discuss how therapeutic stabilization of brain barriers integrity may improve the safety of current therapeutic regimes for treating MS. This may also allow for the development of entirely novel therapeutic approaches aiming to restore brain barriers integrity and thus CNS homeostasis, which may be specifically beneficial for the treatment of progressive MS.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Theodor Kocher Institute

UniBE Contributor:

Nishihara, Hideaki, Engelhardt, Britta

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0171-2004

Publisher:

Springer

Language:

English

Submitter:

Ursula Zingg-Zünd

Date Deposited:

25 Jan 2021 16:35

Last Modified:

16 May 2023 10:47

Publisher DOI:

10.1007/164_2020_407

PubMed ID:

33237504

Uncontrolled Keywords:

Adhesion molecules Arachnoid barrier Blood–brain barrier Blood–cerebrospinal fluid barrier Glia limitans Immune cell trafficking Multiple sclerosis Permeability Tight junctions

BORIS DOI:

10.48350/150899

URI:

https://boris.unibe.ch/id/eprint/150899

Actions (login required)

Edit item Edit item
Provide Feedback